• Skip to main content

Plain Language Summaries

Standalone, citable summaries published in the Future Science Group journals written to be understood by a lay audience

  • How To Publish
  • How to Write Plain Language Summaries
  • Frequently Asked Questions
  • Publications
    • Animated Videos
    • Bladder, Kidney and Genitals
    • Brain and Nerves
    • Cancer
    • Diabetes and Metabolic Hormones
    • Eyes and Vision
    • Heart and Circulation
    • Infections
    • Inflammatory and Immune-related disorders
    • Mental Health
    • Muscle and Bone
    • Rare Diseases
    • Skin
    • Vaccines
  • Advisory Panel
  • Supporters
  • Blog
  • About Us
  • Contact Us

Sep 15 2022

Disease stability over five years in people with multiple sclerosis treated with cladribine tablets: a plain language summary

In this plain language summary of publication from Neurodegenerative Disease Management, Dr Gavin Giovannoni and co-authors provide an overview of their article originally published in the journal Advances in Therapy. In this article, the researchers look at the results from the CLARITY and CLARITY Extension studies to determine what effect a 2-year course of treatment with cladribine tablets had on disability over 5 years in people with multiple sclerosis.

Read the full article here.

The original article on which this summary is based is called ‘Long-Term Disease Stability Assessed by the Expanded Disability Status Scale in Patients Treated with Cladribine Tablets 3.5 mg/kg for Relapsing Multiple Sclerosis: An Exploratory Post Hoc Analysis of the CLARITY and CLARITY Extension Studies’ and was originally published in the journal Advances in Therapy. The original article can be read here.

  • Share on Twitter Share on Twitter
  • Share on Facebook Share on Facebook
  • Share on LinkedIn Share on LinkedIn

Written by Joanne Walker · Categorized: Brain and nerves · Tagged: cladribine tablets, CLARITY, clinical trial, disease stability, EDSS, lay summary, multiple sclerosis

Copyright © 2023 · Plain Language Summaries · Terms and Conditions · Privacy Policy ·